Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8655031 | 0.81 | KDM4E (0.53) | MEN1KMT2AALDH1A1HPGDMAPK1 | |
| SCHEMBL21730077 | 0.81 | MAOB (0.44) | MEN1KMT2AALDH1A1HPGDGFER | |
| SCHEMBL12402049 | 0.78 | SIGMAR1 (0.44) | MEN1KMT2AALDH1A1HPGDL3MBTL1 | |
| SCHEMBL22536007 | 0.78 | KMT2A (0.38) | MEN1KMT2AALDH1A1ALOX15HPGD | |
| SCHEMBL11699938 | 0.77 | ALDH1A1 (0.50) | MEN1KMT2AALDH1A1HPGDGFER | |
| SCHEMBL21730129 | 0.76 | MEN1 (0.37) | MEN1KMT2AALDH1A1HPGDGFER | |
| SCHEMBL3842986 | 0.76 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1ALOX15HPGD | |
| SCHEMBL5671680 | 0.75 | HNF4A (0.38) | MEN1KMT2AALDH1A1ALOX15HPGD | |
| SCHEMBL322061 | 0.74 | KMT2A (0.44) | MEN1KMT2AALDH1A1ALOX15HPGD | |
| SCHEMBL322060 | 0.74 | KMT2A (0.44) | MEN1KMT2AALDH1A1ALOX15HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1668409-A4 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | UNIV CALIFORNIA (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1668409-A2 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | The Regents of The University of California (US) | 2006-06-14 | — | — | EP | claimed |
| US-6862125-B2 | Reversible electro-optic device employing aprotic molten salts and method | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-03-01 | — | — | US | claimed |
| WO-2004099863-A2 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-11-18 | — | — | WO | claimed |
| US-20040227983-A1 | Reversible electro-optic device employing aprotic molten salts and method | LOS ALAMOS NATIOMAL SECURITY, LLC | 2004-11-18 | — | — | US | claimed |
| US-20040223207-A1 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | LOS ALAMOS NATIONAL SECUIRTY, LLC | 2004-11-11 | — | — | US | claimed |
| US-6587251-B2 | Color change of mirror | EXON SCIENCE, INC. (TW) | 2003-07-01 | — | — | US | claimed |
| US-20030063365-A1 | Electrochromic solution containing hydrazone compound and device manufactured with same | SEAGATE TECHNOLOGY LLC | 2003-04-03 | — | — | US | claimed |
| EP-1288275-A2 | Electrochromic solution containing a hydrazone compound and device manufactured with same | Exon Science Inc. (TW) | 2003-03-05 | — | — | EP | claimed |
| EP-1668409-A4 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | UNIV CALIFORNIA (US) | 2008-08-27 | — | — | EP | disclosed |
| US-7317106-B2 | Reversible electro-optic device employing aprotic molten salts and method | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-01-08 | — | — | US | disclosed |
| EP-1668409-A2 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | The Regents of The University of California (US) | 2006-06-14 | — | — | EP | disclosed |
| US-20060012293-A1 | Reversible electro-optic device employing aprotic molten salts and method | LOS ALAMOS NATIONAL SECURITY, LLC | 2006-01-19 | — | — | US | disclosed |
| US-6862125-B2 | Reversible electro-optic device employing aprotic molten salts and method | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-03-01 | — | — | US | disclosed |
| WO-2004099863-A2 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-11-18 | — | — | WO | disclosed |
| US-20040227983-A1 | Reversible electro-optic device employing aprotic molten salts and method | LOS ALAMOS NATIOMAL SECURITY, LLC | 2004-11-18 | — | — | US | disclosed |
| US-20040223207-A1 | REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD | LOS ALAMOS NATIONAL SECUIRTY, LLC | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060012293-A1 | Reversible electro-optic device employing aprotic molten salts and method | ALDH1A2, OTC, AOC1 | MEN1 9/4885KMT2A 1543/4885ALDH1A1 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.